Whats Hot Today : Baidu Inc (ADR) (NASDAQ:BIDU), Conversant, Inc. (NASDAQ:CNVR), Tenet Healthcare Corp. (NYSE:THC), Uroplasty, Inc. (NASDAQ:UPI), AbbVie Inc. (NYSE:ABBV),

German luxury carmaker BMW is teaming up with Chinese internet giant Baidu Inc (ADR) (NASDAQ:BIDU) to start highly automated driving trials in Beijing and Shanghai. Baidu Inc (ADR) (NASDAQ:BIDU) belongs to Technology sector. Its net profit margin is 29.70% and weekly performance is 1.60%. On last trading day company shares ended up $218.23. Baidu Inc (ADR) (NASDAQ:BIDU) distance from 50-day simple moving average (SMA50) is 0.38%.

On Sept.15, The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Conversant, Inc. (NASDAQ:CNVR) in connection with the sale of the Company to Alliance Data Systems Corporation. Conversant, Inc. (NASDAQ:CNVR) shares moved down -0.55% in last trading session and ended the day at $34.25. CNVR Gross Margin is 67.40% and its return on assets is 17.50%. Conversant, Inc. (NASDAQ:CNVR) quarterly performance is 35.32%.

Tenet Healthcare Corp (NYSE:THC) has been given a “B” credit rating by Morningstar. The firm’s “B” rating indicates that the company is a high default risk. They also gave their stock a two star rating. On 30 September, Tenet Healthcare Corp. (NYSE:THC) shares moved down -2.06% and was closed at $59.39. THC EPS growth in last 5 year was -32.10%. Tenet Healthcare Corp. (NYSE:THC) year to date (YTD) performance is 41.00%.

Zacks upgraded shares of Uroplasty (NYSE:UPI) from an underperform rating to a neutral rating in a research note released on Monday morning. They currently have $2.60 target price on the stock. Uroplasty, Inc. (NASDAQ:UPI) ended the last trading day at $2.50. Company weekly volatility is calculated as 4.31% and price to cash ratio as 5.20. Uroplasty, Inc. (NASDAQ:UPI) showed a weekly performance of -1.57%.

Seeking to dissuade any doubters, AbbVie Inc. (NYSE:ABBV) chief executive Richard Gonzalez started the week by sending a memo to Shire employees to say that plans are proceeding apace to acquire Shire. At the same time, Chris Turek, a vp of enterprise strategies at AbbVie, sent a memo to AbbVie employees in which he talked up “similar cultures” and predicted the $54 billion deal would close in the fourth quarter. AbbVie Inc. (NYSE:ABBV) shares moved down -1.30% in last trading session and ended the day at $57.76. ABBV Gross Margin is 76.40% and its return on assets is 14.50%. AbbVie Inc. (NYSE:ABBV) quarterly performance is 2.30%.